HALO logo
halo search icon
Humacyte, Inc.
Humacyte, Inc.
HUMA · NAS

Humacyte, Inc.

US$0.92

Price Arrow0.092 (11.14%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Humacyte, Inc. Overview

HUMA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About HUMA

icon

Website

Humacyte, Inc.

icon

Telephone

icon

Address

Description

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

HUMA Price Chart

Key Stats

Market Cap

US$183.23M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.55 - 2.93

Trade Value (12mth)

US$1,938,989.00

1 week

-11.27%

1 month

25.24%

YTD

-15.35%

1 year

-64.73%

All time high

17.45

Key Fundamentals

EPS 3 yr Growth

122.40%

EBITDA Margin

NaN%

Operating Cashflow

-$105m

Free Cash Flow Return

-232.60%

ROIC

-90.40%

Interest Coverage

-8.90

Quick Ratio

3.00

Other Data

Shares Outstanding (Fully Diluted)

198m

HALO Sector

Other Finance

Next Company Report Date

26-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

HUMA Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
09 May 26
09 May 26

HUMA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.07-1.26-0.26locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.07-1.26-0.26locklocklock
Growth
%locklocklocklock-822.6-17.279.4locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Humacyte, Inc. (HUMA:NAS)?
Halo FAQ
The current share price of Humacyte, Inc. (HUMA:NAS) is USD$0.92.
What is the 52-week high share price for Humacyte, Inc. (HUMA:NAS)?
Halo FAQ
The 52-week high share price for Humacyte, Inc. (HUMA:NAS) is USD$2.93.
What is the 52-week low share price for Humacyte, Inc. (HUMA:NAS)?
Halo FAQ
The 52-week low share price for Humacyte, Inc. (HUMA:NAS) is USD$0.55.
What is the dividend yield for Humacyte, Inc. (HUMA:NAS)?
Halo FAQ
Humacyte, Inc. (HUMA:NAS) does not pay a dividend.
What was Humacyte, Inc. (HUMA:NAS) last dividend payment?
Halo FAQ
Humacyte, Inc. (HUMA:NAS) does not pay a dividend.
What is the franking level for Humacyte, Inc. (HUMA:NAS)?
Halo FAQ
Humacyte, Inc. (HUMA:NAS) has a franking level of 0.00%.
In which sector is Humacyte, Inc. (HUMA:NAS) classified?
Halo FAQ
Humacyte, Inc. (HUMA:NAS) is classified in the Other Finance.

See beyond the curve.

One solution for research, investing and portfolio management.